Small Cap NAII - 500 Beiträge pro Seite

[Kostolanys Erbe]

Hi Leute,

was haltet ihr von diesem Unternehmen. Die letzten Zahlen waren sehr gut. Das Unternehmen ist meiner Meinung nach in einer Branche die stark wachsen wird.

Natural Alternatives International, Inc. Reports Record Breaking Net Sales for Fiscal 2004
MONDAY, AUGUST 30, 2004 8:50 AM


SAN MARCOS, Calif., Aug 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- Natural Alternatives International, Inc. ("NAI") (NAII) , a leading formulator and manufacturer of customized nutritional supplements, today announced that its net sales for fiscal 2004 were $78.5 million, the highest level in the company`s history. Net income for the fiscal year ended June 30, 2004 was $3.0 million, or $0.48 per diluted share. Net income improved $1.9 million, or 171%, over the prior year.

For the fiscal year ended June 30, 2004 net sales increased 40% to $78.5 million from $56.0 million in the prior year. Sales growth included a 50% increase in private label contract manufacturing sales. Net income increased to $3.0 million or $0.48 per diluted share, which compared favorably to $1.1 million or $0.18 per diluted share in the prior year.

NAI also reported record net sales for its fourth quarter ended June 30, 2004. Fourth quarter net sales of $23.3 million represents an increase of $2.1 million, or 10%, over the prior quarter, which was the Company`s previous high. Net sales increased $7.3 million, or 45%, over the comparable quarter last year. Net income for the fourth quarter increased to $1.0 million or $0.15 per diluted share from $247,000 or $0.04 per diluted share for the comparable quarter last year.

As of June 30, 2004, NAI had cash and working capital of $7.5 million and $17.5 million, respectively, compared to $5.5 million and $12.3 million, respectively, at June 30, 2003. During fiscal 2004, inventory increased $5.0 million in response to higher anticipated net sales and customer delivery requirements. In addition, the Company invested $3.3 million primarily in manufacturing equipment in fiscal 2004.

"We continue to focus on serving the needs of our valued primary customers and celebrate their tremendous growth," stated CEO Mark Le Doux. "In fiscal 2004 we were also able to leverage our product formulation, regulatory affairs and the introduction of innovative products containing proprietary ingredients to obtain new customers. Our fiscal 2004 accomplishments demonstrate our team`s commitment to providing our customers with superior science-based products and value added services while building long term value for our stockholders."

President Randell Weaver commented, "We are pleased with the fourth quarter and the full year. We have now posted three consecutive years of increased revenues and operating profits and expect to continue these trends. Our balance sheet reflects an improved cash position due to increased profits, effective working capital management and long-term borrowings from our new credit facilities. Cash flow from operations was $3.3 million even with significant investments in inventory and accounts receivable. During the year, we invested heavily in our facilities and equipment and expect to continue those investments in fiscal 2005. We also continue to evaluate expansion opportunities that could increase product lines or enhance our manufacturing capabilities."

NAI, headquartered in San Marcos, California, is a leading formulator and manufacturer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to the client including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at http://www.nai-online.com.

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to future financial and operating results and our ability to continue to improve profitability, maintain adequate financing, improve liquidity, maintain revenue growth, and implement our strategic plan. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI`s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

CONTACT - John R. Reaves, Chief Financial Officer, Natural Alternatives International, Inc., 760-736-7700 or [e-mail].



NATURAL ALTERNATIVES INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

June 30, June 30,
2004 2003
--------- ---------

ASSETS
Cash and cash equivalents $7,495 $5,482
Accounts receivable, net 8,889 5,668
Inventories, net 12,863 7,845
Deferred income taxes 1,010 --
Other current assets 633 766
--------- ---------
Total current assets 30,890 19,761
Property and equipment, net 11,380 10,820
Other assets 198 143
--------- ---------
Total Assets $42,468 $30,724
========= =========
LIABILITIES AND STOCKHOLDERS` EQUITY
Current liabilities $13,422 $7,440
Deferred income taxes 717 --
Long-term debt, less current installments 3,841 2,386
Deferred rent 220 --
Long-term pension liability 140 121
--------- ---------
Total Liabilities 18,340 9,947
--------- ---------
Stockholders` Equity 24,128 20,777
--------- ---------
Total Liabilities and Stockholders` Equity $42,468 $30,724
========= =========


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)

Three months ended Year ended
June 30, June 30,
--------------------- --------------------
2004 2003 2004 2003
--------- --------- --------- ---------

NET SALES $23,350 $16,061 $78,534 $55,962
Cost of goods sold 17,874 12,414 59,964 42,781
--------- --------- --------- ---------
Gross profit 5,476 3,647 18,570 13,181
Selling, general &
administrative expenses 4,279 3,347 15,188 12,012
--------- --------- --------- ---------
INCOME FROM OPERATIONS 1,197 300 3,382 1,169
Other expense, net (242) (27) (358) (17)
--------- --------- --------- ---------
INCOME BEFORE INCOME
TAXES 955 273 3,024 1,152
Provision (benefit)
for income taxes (47) 26 24 47
--------- --------- --------- ---------
NET INCOME $1,002 $247 $3,000 $1,105
========= ========= ========= =========
NET INCOME PER
COMMON SHARE:
Basic $0.17 $0.04 $0.51 $0.19
========= ========= ========= =========
Diluted $0.15 $0.04 $0.48 $0.18
========= ========= ========= =========
WEIGHTED AVERAGE COMMON
SHARES OUTSTANDING:
Basic shares 5,881,440 5,815,132 5,843,241 5,809,140
========= ========= ========= =========
Diluted shares 6,606,264 6,071,709 6,304,167 6,021,155
========= ========= ========= =========



SOURCE Natural Alternatives International, Inc.

John R. Reaves, Chief Financial Officer of Natural Alternatives
International, Inc., [phone], [e-mail]


http://www.nai-online.com

Marktkapitalisierung bei 78 mio dollar umsatz und wachstum ein witz....!!!

Market cap: $ 54.31M

Shares out: 5.89M

Per share data
Earnings (1 year): 0.48

Current P/E Ratio: 25.61

Cash Flow: $ 0.89

Cash (last quarter): n/a

Annual Dividend: n/a

Book Value: $ 3.66

und der Vorstand kauft die aktien selbst!!!!!

kosto

[Kostolanys Erbe]

hi leute,

schade das sich niemand für so einen small cap interessiert! aktuell 9,39 dollar





kosto

[Kostolanys Erbe]

anbei eine Empfehlung zu NAII :

dazu muss ich aber sagen, das ich nicht aufgrund Global biotech auf diesen wert aufmerksam wurde, sondern schon länger auf der watchlist hatte.

Natural Alternatives ein klarer Kauf


Die Experten von "Global Biotech Investing" empfehlen die Aktie von Natural Alternatives International (ISIN US6388423021/ WKN 880900) zum Kauf. Das Unternehmen habe jüngst neue Rekordzahlen verkünden können. So habe der Umsatz gegenüber dem Vorjahr um 40% auf einen neuen Höchststand von 78,5 Mio. USD zulegen können. Der Nettogewinn habe sich gegenüber dem Geschäftsjahr 2003 um 171% auf 3 Mio. USD oder 0,48 USD je Aktie erhöht. Des Weiteren habe man auch für das 4. Quartal Rekordumsätze in Höhe von 23,3 Mio. USD verkünden können. Gegenüber dem 3. Quartal sei dies eine 10-prozentige Steigerung und gegenüber dem Vorjahr bedeute dies sogar ein Plus von 45%. Im gleichen Zeitraum habe der Nettogewinn von 247.000 USD auf 1 Mio. USD zugelegt. Die Wertpapierexperten würden damit rechnen, dass die Gesellschaft ihren Gewinn im gerade begonnenen Geschäftsjahr auf mindestens 0,75 USD je Aktie ausbauen könne. Der Titel wäre somit auf Basis der diesjährigen Gewinne mit einem KGV von 12 bewertet. Für die Experten von "Global Biotech Investing" ist der Titel von Natural Alternatives ein klarer Kauf.

Kosto

[Kostolanys Erbe]

hi leute,

mit NAII konnte man gute gewinne machen. nach schliessung des gaps stehen die chancen für ein wiedereinstieg auf grün.
die letzten q-zahlen waren auch sehr gut. das management kauft selber aktien...

market-cap von 48 mio !!ein witz! schaut doch mal die umsätze aus einem quartal an!!! 6 mio ausstehende aktien. book value fast 4$ und cash von 7,5 mio $ !!!!!????
klar unterbewertet!


was meint ihr? zumindest watchlist!

kosto

Natural Alternatives International, Inc. Reports 36% Net Sales Increase and Net Income of $0.13 Per Diluted Share for the First Three Months of Fiscal 2005
MONDAY, OCTOBER 25, 2004 8:50 AM
- PR Newswire


SAN MARCOS, Calif., Oct 25, 2004 /PRNewswire-FirstCall via COMTEX/ -- Natural Alternatives International, Inc. ("NAI") (NAII) , a leading formulator and manufacturer of customized nutritional supplemen:s, today announced net income of $852,000 or $0.13 per diluted share on net sales of $22.7 million for the three months ended September 30, 2004.

First quarter net sales increased 36% to $22.7 million from $16.7 million for the comparable quarter last year. Net sales growth resulted in part from a 50% increase in private label contract manufacturing sales. Income from operations increased by 121% to $1.4 million from $630,000 in the comparable quarter last year. Net income increased to $852,000 or $0.13 per diluted share from $567,000 or $0.09 per diluted share for the comparable quarter last year.

As of September 30, 2004, NAI had cash and working capital of approximately $3.2 million and $16.3 million, respectively, compared to $7.5 million and $17.5 million, respectively, at June 30, 2004. First quarter cash used in operating activities was $1.6 million principally due to compensation payments of $1.6 million under our fiscal 2004 Management Incentive Plan resulting from our growth in earnings in 2004. Additionally, first quarter capital expenditures of $2.6 million resulted from our investment in the expansion of our Vista, California facility and acquisition of additional manufacturing equipment to expand production capacity. We funded our capital expenditures from available cash on hand. As of September 30, 2004 we had $7.6 million available under our working capital line of credit.

"We begin our 25th year building upon the remarkable financial performance of fiscal 2004. First quarter income from operations improved 16% over the fourth quarter of fiscal 2004," stated CEO Mark Le Doux. "Our first quarter net sales were in line with our growth plans for fiscal 2005. Building on our reputation of quality products and turnkey services, we are beginning to see brand preference develop in our contract manufacturing business. We look to increase our net sales and expand our customer base, while serving the needs of our valued primary customers who contribute to the foundation of our sustainable growth plans."

President Randell Weaver commented, "Growth like we experienced in fiscal 2004 requires investment in expansion. We look forward to consolidating our manufacturing activities into our new manufacturing space in our fiscal third quarter. We believe our Vista, California expansion into an additional 46,000 square-foot production facility will meet increased demand and further streamline our manufacturing capabilities. We are pleased that capital expenditures, working capital, total debt and cash used in operations were in line with our growth plans for fiscal 2005."

NAI, headquartered in San Marcos, California, is a leading formulator and manufacturer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to the client including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at www.nai-online.com.

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to future financial and operating results and our ability to continue to improve profitability, maintain adequate financing, improve liquidity, maintain revenue growth, complete the expansion of our manufacturing facilities and implement our strategic plans. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI`s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

For further information, please contact John R. Reaves, Chief Financial Officer of Natural Alternatives International, Inc., [phone], [e-mail].


NATURAL ALTERNATIVES INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

September 30, June 30,
2004 2004
------------ ----------
(Unaudited)
ASSETS
Cash and cash equivalents $3,204 $7,495
Accounts receivable, net 9,394 8,889
Inventories, net 13,882 12,863
Deferred income taxes 951 1,010
Other current assets 1,199 633
------------ ----------
Total current assets 28,630 30,890
Property and equipment, net 13,334 11,380
Other assets 185 198
------------ ----------
Total Assets $42,149 $42,468
============ ==========

LIABILITIES AND STOCKHOLDERS` EQUITY
Current liabilities $12,363 $13,422
Long-term debt, less current installments 3,632 3,841
Deferred income taxes 717 717
Deferred rent 256 220
Long-term pension liability 146 140
------------ ----------
Total Liabilities 17,114 18,340
------------ ----------
Stockholders` Equity 25,035 24,128
------------ ----------
Total Liabilities and Stockholders` Equity $42,149 $42,468
============ ==========


NATURAL ALTERNATIVES INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)

Three months ended
September 30,
-------------------------
2004 2003
------------ ----------
(Unaudited)
NET SALES $22,727 $16,721
Cost of goods sold 17,409 12,575
------------ ----------
Gross profit 5,318 4,146
Selling, general & administrative expenses 3,924 3,516
------------ ----------
INCOME FROM OPERATIONS 1,394 630
Other expense, net 50 41
------------ ----------
INCOME BEFORE INCOME TAXES 1,344 589
Provision for income taxes 492 22
------------ ----------

NET INCOME $852 $567
============ ==========

NET INCOME PER COMMON SHARE:
Basic $0.14 $0.10
============ ==========
Diluted $0.13 $0.09
============ ==========

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic shares 5,923,766 5,820,709
============ ==========
Diluted shares 6,447,677 6,106,834
============ ==========


Market cap: $ 48.32M

Shares out: 5.93M


Per share data
Earnings (1 year): 0.52

Current P/E Ratio: 15.67

Cash Flow: $ 0.95

Cash (last quarter): $ 7.50M

Annual Dividend: n/a

Book Value: $ 3.95

EBITDA: $ 5.97M


Management effectiveness
Return on Equity (1 year): 15.37%

Return on assets (1 year): 10.91%

Return on Investment (1 year): n/a


Valuation ratios
Price/Earnings (1 year): 16.54

Price/Book (1 year): 2.18

Price/Cash Flow (1 year): 10.01


Profitability
Gross Margin (1 year): 23.40%

Operating Margin (1 year): 6.13%

Profit Margin (1 year): 3.75%

M = Millions B=Billions

[Kostolanys Erbe]

leider keine resonanz,

aber schaut auf naii !!!

kosto
:-)

[doktor7]

Hallo Kosto,
Wollte schon bei 7 rein, hat gottseidank nich geklappt.
Blickst Du, warum es so abwärts geht?
Aktuelle News dazu? Oder hast Du Dich bereits wieder
abgewendet?
gruß....d7

[JuanLesPins]

Schau aufs Handelsvolumen.

In Deutschland nix und in Amiland musste die Luft anhalten, wenn de im Verkaufsfalle Abnehmer finden willst.

[doktor7]

Ja so siehts aus!
will mich nur vorbereiten für den Fall X.
In erster Linie charttechnische Analysen
vorhanden. Im Moment sicher kein Kauf.
Trotzdem auf meiner Watchlist.